29218-21-1

• 常用中文名：5-(羟基甲基)-3-苯基噁唑啉-2-酮
• 常用英文名：3-Phenyl-5-(hydroxymethyl)oxazolidine-2-one
• CAS号：29218-21-1
• 分子式：C₁₀H₁₁NO₃
• 分子量：193.19900
• 发布时间：2019-01-01 12:01:37
• 更新时间：2024-01-08 15:53:27

名称

• 中文名: 5-(羟基甲基)-3-苯基噁唑啉-2-酮
• 英文名: 5-(Hydroxymethyl)-3-phenyl-1,3-oxazolidin-2-one
• 英文别名: 5-Hydroxymethyl-3-phenyl-2-oxazolidinone; 2-Oxazolidinone,5-hydroxymethyl-3-phenyl; 5(R)-hydroxymethyl-3-phenyloxazolidin-2-one; 5-hydroxymethyl-3-phenyl-oxazolidin-2-one; 5-(hydroxymethyl)-3-phenyl-2-oxooxazolidine; 3-phenyl-5-(hydroxymethyl)-2-oxazolidinone; (R,S)-5-hydroxymethyl-3-phenyl-2-oxazolidinone; 3-Phenyl-5-(hydroxymethyl)oxazolidine-2-one

物化性质

• 密度: 1.287g/cm3
• 沸点: 326.4ºC at 760mmHg
• 分子式: C₁₀H₁₁NO₃
• 分子量: 193.19900
• 闪点: 151.2ºC
• 精确质量: 193.07400
• PSA: 49.77000
• LogP: 1.06910
• 蒸汽压: 8.8E-05mmHg at 25°C
• 折射率: 1.578

安全

• 海关编码: 2934999090

合成路线

947233-24-1 ~% 29218-21-1

文献：MERCK and CO., INC. Patent: WO2009/94265 A1, 2009 ; Location in patent: Page/Page column 60 ; WO 2009/094265 A1

5840-15-3 105-58-8 ~57% 29218-21-1

文献：TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; CANNEY, Daniel, J.; BHANDARE, Richie, R.; BLASS, Benjamin, E.; ABOU-GHARBIA, Magid Patent: WO2014/85413 A1, 2014 ; Location in patent: Paragraph 00217 ;

5840-15-3 110-71-4 105-58-8 ~% 29218-21-1

文献：E. I. DuPont de Nemours and Company Patent: US4461773 A1, 1984 ;

108-86-1 7517-99-9 ~20% 29218-21-1

文献：Mallesham; Rajesh; Reddy, P Rajamohan; Srinivas; Trehan, Sanjay Organic letters, 2003 , vol. 5, # 7 p. 963 - 965

2461-40-7 101-99-5 ~% 29218-21-1

文献：Adibpour, Neda; Khalaj, Ali; Rajabalian, Saeed European Journal of Medicinal Chemistry, 2010 , vol. 45, # 1 p. 19 - 24

74497-02-2 ~% 29218-21-1

文献：TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; CANNEY, Daniel, J.; BHANDARE, Richie, R.; BLASS, Benjamin, E.; ABOU-GHARBIA, Magid Patent: WO2014/85413 A1, 2014 ;

海关

海关编码	2934999090
中文概述	2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素	品名, 成分含量, 用途
Summary	2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%